Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Heart Failure × pertuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 88 HER2-positive Breast Cancer 8 Neoplasms 7 Neoplasm Metastasis 5 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Triple Negative Breast Neoplasms 3 Inflammatory Breast Neoplasms 3 Hematologic Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Salivary Gland Neoplasms 2 Ovarian Neoplasms 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Locally Advanced Breast Cancer 2 HER2-positive Metastatic Breast Cancer 2 HER2-positive Early Breast Cancer 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Ductal, Breast 2 Breast Neoplasms, Male 2 Brain Neoplasms 2 Urinary Bladder Neoplasms 1 Thrombocytosis 1 Stomach Neoplasms 1 Solid Tumor 1 Skin Neoplasms 1 Sarcoma 1

Interventions

Echocardiography 4 Standard of Care 3 Exercise 3 Electrocardiography 3 sacubitril and valsartan sodium hydrate drug combination 2 Surveys and Questionnaires 2 Spironolactone 2 Nutrition Assessment 2 Ivabradine 2 Carvedilol 2 Blood Specimen Collection 2 Atorvastatin 2 ziprasidone 1 pertuzumab 1 pegfilgrastim 1 nicotinamide-beta-riboside 1 empagliflozin 1 dapagliflozin 1 candesartan 1 Zolpidem 1 Watchful Waiting 1 Warfarin 1 Vincristine 1 Vecuronium Bromide 1 Vascular Stiffness 1 Vancomycin 1 Valsartan 1 Trastuzumab 1 Tranexamic Acid 1 Tobramycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04680442 2025-04-06

SCHOLAR-2

Population Health Research Institute

Phase 2 Recruiting

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡